Home News Interviews Companies Videos Markets Subscribe

The Markets

Sort by Price Sort by Change ($)Sort by Change (%)

close X

Core One Labs Inc.

close X

Cybin Corp

close X

Field Trip Health

close X

Havn Life

close X

Mind Cure Health

close X

Mydecine Innovations Group

close X

NeonMind Biosciences Inc.

close X

Nova Mentis Life Science

close X

Novamind Inc.

close X

Optimi Health

close X

Pharmather

close X

PsyBio Therapeutics

close X

Psyched Wellness

close X

Psyence Group

close X

Pure Extracts Corp

close X

Silo Wellness

close X

Tryp Therapeutics

close X

Algernon Pharmaceuticals

close X

Champignon Brands

close X

Horizons ETFs Management Inc.

close X

Mind Medicine (MindMed)

close X

Mindset Pharma

close X

Numinus

close X

Revive Therapeutics

close X

Seelos Therapeutics

close X

Compass Pathways

close X

EGF Theramed Health Corp

close X

Entheon Biomedical

close X

Lobe Sciences

close X

Pharmadrug Inc.

close X

Red Light Holland

close X

Thoughtful Brands Inc.

Features

Field Trip Health: Video Profile

News

PsyBio Therapeutics Retains KCSA Strategic Communications for Investor Relations Services

News

Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

News

MINDCURE Announces Additional Equity Investment in ATMA

GET THE HEADLINES + UPDATES

Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.

Thanks for subscribing!

Oops! Something went wrong while submitting the form.

NeonMind Biosciences Inc.

Mydecine Innovations Group

Nova Mentis Life Science

Psilotec Health Solutions

Algernon Pharmaceuticals

Aja Ventures

Horizons ETFs Management Inc.

Seelos Therapeutics

Numinus

Champignon Brands

Mind Medicine (MindMed)

Gilgamesh Pharmaceuticals

Wake Network

Molecular Science Corp.

Thoughtful Brands Inc.

Lophora

2 3 5

Cookie Policy: We use cookies on this site to track usage and help improve the user experience. By continuing to use our site, you are agreeing to this policy.

Accept